Literature DB >> 1079048

Effects of prenylamine on cardiac membrane currents and contractility.

H G Haas, R Kern, C Benninger, H M Einwächter.   

Abstract

The influence of prenylamine on the electrical and mechanical activity of frog atrial muscle fibers has been studied under voltage clamp conditions. At a concentration of 10-4 M, prenylamine blocks the action potential without much affecting the resting potential. The drug depresses the peak transient sodium conductance with a dissociation constant of 1.7 times 10-5 M and on a one-to-one stoichiometric basis. The curve relating peak sodium conductance to membrane potential is slightly shifted in the direction of hyperpolarization. The time to peak sodium current and the rate of sodium inactivation are not significantly altered. With 2 times 10-5 M prenylamine, the steady-state sodium inactivation curve is shifted by 5 mV to more negative membrane potentials but the decreased availability of the sodium system at the resting level is not sufficient to account for the reduction of sodium current. Recovery from sodium inactivation upon repolarization is distinctly slowed. The slow (secondary) inward current carried by calcium and/or sodium and the steady-state outward current are also depressed by prenylamine. The phasic (twitch-like) contraction related to the slow inward current is slightly decreased. The tonic (sustained) contraction associated with long-lasting depolarizations is increased and the time course of relaxation is retarded by prenylamine.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1079048

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  8 in total

1.  [Transmembrane inward currents during excitation of the heart (author's transl)].

Authors:  M Kohlhardt
Journal:  Klin Wochenschr       Date:  1975-12-01

2.  Calcium-sodium antagonism on the frog's heart: a voltage-clamp study.

Authors:  C Benninger; H M Einwächter; H G Haas; R Kern
Journal:  J Physiol       Date:  1976-08       Impact factor: 5.182

3.  Structure-activity studies on nifedipine in isolated cardiac muscle.

Authors:  R Rodenkirchen; R Bayer; R Steiner; F Bossert; H Meyer; E Möller
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-12       Impact factor: 3.000

4.  Prenylamine-induced contracture of frog skeletal muscle.

Authors:  E B Kirsten; K C Lustig
Journal:  Br J Pharmacol       Date:  1977-05       Impact factor: 8.739

5.  The haemodynamic and metabolic effects of MG 8926, a prospective antidysrhythmic and antianginal agent.

Authors:  R J Marshall; J R Parratt
Journal:  Br J Pharmacol       Date:  1977-02       Impact factor: 8.739

6.  The effects of prenylamine on single ventricular myocytes of guinea-pig.

Authors:  Y Shimoni; P Posner; A J Spindler; D Noble
Journal:  Br J Pharmacol       Date:  1988-06       Impact factor: 8.739

7.  Effect of phentolamine, alprenolol and prenylamine on maximum rate of rise of action potential in guinea-pig papillary muscles.

Authors:  H Sada
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-10       Impact factor: 3.000

Review 8.  Withdrawal of prenylamine: perspectives on pharmacological, clinical and regulatory outcomes following the first QT-related casualty.

Authors:  Rashmi R Shah; Peter D Stonier
Journal:  Ther Adv Drug Saf       Date:  2018-06-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.